Creative Planning
SPHS

Creative Planning’s Sophiris Bio, Inc. SPHS Stock Holding History

Creative Planning’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,900
Closed -$11K – 4664
2017
Q2 		$11K Buy
4,900
+500
+11% +$1.23K ﹤0.01% 3602
2017
Q1 		$12K Sell
4,400
-1,200
-21% -$3.29K ﹤0.01% 3514
2016
Q4 		$16K Sell
5,600
-19,600
-78% -$55.5K ﹤0.01% 3253
2016
Q3 		$78K Buy
25,200
+24,300
+2,700% +$91.4K ﹤0.01% 2030
2016
Q2 		$2K Sell
900
-3,361
-79% -$4.64K ﹤0.01% 4122
2016
Q1 		$6K Buy
4,261
+2,400
+129% +$4.23K ﹤0.01% 3544
2015
Q4 		$3K Buy
1,861
+900
+94% +$1.33K ﹤0.01% 3981
2015
Q3 		$1K Buy
+961
New +$836 ﹤0.01% 4266
2015
Q2 		– Sell
-961
Closed -$1K – 4181
2015
Q1 		$1K Buy
+961
New +$513 ﹤0.01% 4172

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Creative Planning's SPHS Position: Q3 2017 in Review

Creative Planning sold out of Sophiris Bio, Inc. (SPHS) in Q3 2017, closing a stake of 4,900 shares — an estimated $11K sold.

Creative Planning first reported a position in SPHS in Q1 2015 and held it in 9 quarters. The position peaked at $78K in Q3 2016. 25 funds tracked by Wall St. Rank hold SPHS as of Q3 2017.

  • Creative Planning reported no remaining Sophiris Bio, Inc. position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 4,900 Sophiris Bio, Inc. shares in Q3 2017, an estimated $11K.
  • Creative Planning first reported a position in Sophiris Bio, Inc. in Q1 2015 and held it in 9 quarters.
  • Creative Planning's Sophiris Bio, Inc. position peaked at $78K in Q3 2016.
  • 25 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.